Arrowhead heralded the results as proof of concept that inhibiting the Activin E pathway can improve body composition and enhance weight loss as compared to tirzepatide alone, particularly in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback